Advertisement
Advertisement

COLL

COLL logo

Collegium Pharmaceutical, Inc. Common Stock

29.47
USD
Sponsored
+0.36
+1.24%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

29.47

0.00
0.00%

Collegium Pharmaceutical, Inc. Common Stock Profile

About

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are in different clinical trial. It developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, United States.

Info & Links

CEO

Vikram Karnani

Headquarters

100 Technology Center Drive
Stoughton, MA 02072, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.collegiumpharma.com

Auditor

Deloitte & Touche LLP

Share holders

11

Employees

423

Collegium Pharmaceutical, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

955.82M

Enterprise Value

1.90B

Enterprise Value/EBITDA(ttm)

4.86

Price to Earnings Ratio(ttm)

4.22

Price to Sales(ttm)

1.18

Price to Book(mrq)

3.06

Price to Cash(ytd)

1.94

Profitability

Gross Margin(ttm)

59.99%

Operating Margin(ttm)

33.96%

Profit Margin(ttm)

5.82%

Return on Equity(ttm)

91.43%

Return on Invested Capital(ttm)

4.88%

Return on Assets(ttm)

15.57%

Income Statement

Revenue(ttm)

808.21M

Revenue Per Share(ttm)

24.83

Gross Profit(ttm)

485.09M

EBITDA(ttm)3

390.33M

Net Income Available to Common(ttm)

47.92M

Diluted EPS(ttm)

1.24

Share Statistics

Beta (5Y Monthly)

0.73

52-Week Change

-10.53%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

32.56M

Dividend Yield

0.00%

Float4

31.83M

% Held by Insiders

1.85%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

149.32M

Total Cash Per Share(mrq)

4.59

Total Debt(mrq)

1.09B

Total Debt/Equity(mrq)

349.96%

Current Ratio(mrq)

1.03%

Quick Ratio(mrq)

1.62%

Book Value Per Share(mrq)

9.60

Cash Flow

Operating Cash Flow Per Share(ytd)

3.96

Free Cash Flow(ytd)

127.67M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement